BioPharmX to Present at 30th Annual ROTH Conference
Mar 5, 2018
MENLO PARK, Calif., March 5, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it will present its updated corporate presentation at the 30th Annual ROTH Conference in Orange County, Calif., where it will also be webcast live.
Anja Krammer, president and co-founder of BioPharmX, will provide an updated overview of the company at the conference on Monday, March 12, at 4:30 p.m. PDT in Blue – Salon 2 at The Ritz-Carlton hotel in Dana Point.
The live webcast will be available at http://wsw.com/webcast/roth32/bpmx/ and a replay will be accessible for 90 days following the presentation.
The annual ROTH Conference, hosted by ROTH Capital Partners March 11-13, gathers close to 550 companies and over 4,700 attendees, featuring presentations from public and private companies in a variety of sectors including healthcare.
The compensation committee of BioPharmX Corporation's board of directors awarded a non-qualified stock option to purchase 400,000 shares of BioPharmX Corporation's common stock at an exercise price of $0.19 to an employee. The stock option will vest at the rate of 25% of the shares on the first anniversary of the commencement of employment and then one forty-eighth (1/48) of the shares monthly thereafter, subject to the employee's continued service with BioPharmX. The stock option grant was granted as an inducement material to the employee's employment in accordance with Section 711(a) of the NYSE American Company guide.
About BioPharmX® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.
BioPharmX is a registered trademark of BioPharmX, Inc.
SOURCE BioPharmX Corporation
For further information: For further information: Nina Brauer, Senior Manager, Marketing & Communications, email@example.com, (650) 889-5030, Investors, firstname.lastname@example.org